FACTORS AFFECTİNG ENTERAL FEEDİNG INTOLERANCE İN INTENSİVE CARE UNİT PATİENTS

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorEda Cirit Bardakçi

About this trial

Enteral nutrition is the first-line nutritional support method in critically ill patients because it helps preserve gastrointestinal system integrity, reduce the risk of infection, and meet metabolic requirements. However, gastrointestinal motility is frequently impaired in critically ill patients due to physiological stress, hemodynamic instability, sedative and vasopressor medications, mechanical ventilation, and underlying diseases. This may result in enteral feeding intolerance (EFI), which complicates nutritional management.

This prospective observational study aims to determine the demographic, clinical, laboratory, and treatment-related factors associated with enteral feeding intolerance in adult intensive care unit patients and to evaluate the association between enteral feeding intolerance and morbidity and mortality.

Adult patients who are started on enteral nutrition in the Anesthesiology and Reanimation Intensive Care Unit will be prospectively followed. No additional intervention will be performed. Patients will be monitored according to routine intensive care and enteral nutrition protocols. Enteral feeding intolerance and potentially associated factors will be recorded prospectively.

The study is planned to include 102 patients.

Eligibility criteria

Qualifiers

Age ≥18 years

Admission to the Anesthesia Intensive Care Unit

Enteral nutrition planned or initiated during intensive care unit admission

Expected to require enteral nutrition during intensive care unit follow-up

Disqualifiers

Age <18 years

Patients receiving only parenteral nutrition

Patients in whom enteral nutrition is contraindicated throughout the observation period

Patients with insufficient data for evaluation of enteral feeding tolerance

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

This trial has no locations

Sponsors and collaborators

Eda Cirit Bardakçi

Lead sponsor

Ankara Ataturk Sanatorium Training and Research Hospital

Sponsor institution